News & Articles

Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models

The agreement will provide prevalidated hepatocytes for use on innovative organ-on-a-chip range

The partnership between Fusion Antibodies and BioTickle delivers value with proprietary antibody discovery, engineering and cell line technologies

The tool enables accurate modelling of the human colon and the mucosal barrier

Team at the Karl Landsteiner University of Health Sciences in Krems identifies strong correlation between cachexia and markers of bone loss

Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process

This tool enables thousands of experiments to run simultaneously on a single polymer chip

Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells

Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells

The cell lines offer researchers a diverse cohort of patient specific models to accelerate drug development

Findings explain higher risk of heart attack in people with diabetes, even after treatment

The drug aims to treat patients with myelodysplastic syndromes

The collaboration will advance software-enabled analysis, data visualization and more for research and industry

Largest review of all large-scale studies to date finds red and processed meat increase the risk of heart disease

The cutting-edge SP i-Dositecno robotic filling and capping equipment will be installed in NIBRT’s global center of excellence for bioprocessing training and research

Laboratories all over the world are being asked to convey test results rapidly to enable prompt reactions